Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
01/11/2007 | CA2613059A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect, process for their manufacture and use thereof as medicaments |
01/11/2007 | CA2611867A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
01/11/2007 | CA2611438A1 Cyclic anilino-pyridinotriazines |
01/10/2007 | EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
01/10/2007 | EP1741703A1 Pyridone derivative |
01/10/2007 | EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
01/10/2007 | EP1740591A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
01/10/2007 | EP1740589A1 Novel 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones, production and use thereof as medicaments |
01/10/2007 | EP1740586A2 Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one |
01/10/2007 | EP1740585A1 Enantiomer-pure hexahydro- pyrrolocyclopenta- pyridine derivatives |
01/10/2007 | EP1740584A1 Fused quinoline derivative and use thereof |
01/10/2007 | EP1740577A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
01/10/2007 | EP1740570A2 Novel gamma secretase inhibitors |
01/10/2007 | EP1740551A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
01/10/2007 | EP1740531A1 Indene derivatives and process for the preparation thereof |
01/10/2007 | EP1620105B1 (6-(phenoxy)-pyrido¬3,4-d|pyrimidin-2-yl)-amine derivatives as p38 kinase inhibitors for the treatment of inflammatory conditions such as rheumatoid arthritis |
01/10/2007 | EP1521583B1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo (2,1-b)-quinazolinone derivatives |
01/10/2007 | EP1443927B1 Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma |
01/10/2007 | EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase |
01/10/2007 | CN1894260A Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
01/10/2007 | CN1894258A Compositions useful as inhibitors of protein kinases |
01/10/2007 | CN1894249A Spiropiperidine derivatives for controlling pests |
01/10/2007 | CN1894248A Synthesis of a polymorph of 4-amino-5-chlor0-2-methoxy-n-(1-azabicyclo[3.3.1]non-4-yl)benzamide hydrochloride hydrate |
01/10/2007 | CN1894247A Bispidon-derivated ligands and complex for catalytically bleaching a substrate |
01/10/2007 | CN1894246A Novel crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt |
01/10/2007 | CN1894245A Pyrido[2,3-d]pyrimidine-2,4-diamines as PDE2 inhibitors |
01/10/2007 | CN1894244A Aryl ether substituted imidazoquinolines |
01/10/2007 | CN1894243A 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
01/10/2007 | CN1894234A 二肽基肽酶抑制剂 Dipeptidyl peptidase inhibitors |
01/10/2007 | CN1894222A Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
01/10/2007 | CN1894212A Near-infrared fluorescent contrast medium |
01/10/2007 | CN1893953A Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists |
01/10/2007 | CN1893951A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
01/10/2007 | CN1893943A Pyrazolopyridines and analogs thereof |
01/10/2007 | CN1891699A Therapeutic morpholino-substituted compounds |
01/10/2007 | CN1891696A Dissymmetrical diazo compounds, compositions comprising them, method of coloring, and device |
01/10/2007 | CN1891695A Symmetrical diazo compounds, compositions comprising them, method of coloring, and device |
01/10/2007 | CN1891693A Therapeutic morpholino-substituted compounds |
01/10/2007 | CN1891691A Symmetrical diazo compounds, compositions comprising them, method of coloring, and device |
01/10/2007 | CN1891689A Aliphatic nitrogen - containing 5 - membered ring compound |
01/10/2007 | CN1294134C Cyclohexylphenyl vasopression agonists |
01/10/2007 | CN1294131C Pyrimidine compound |
01/10/2007 | CN1294130C Substituted pyrazoles |
01/10/2007 | CN1293878C Preventing or therapeutic agent for eye fatigue and pseudomyopia |
01/09/2007 | US7161035 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
01/09/2007 | US7161007 Oxidation of dihydroquinacridone salt with peroxide in the presence of catalyst and anthraquinonedisulfonic acid as catalyst |
01/09/2007 | US7160920 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
01/09/2007 | US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives |
01/09/2007 | US7160899 Use of at least one compound with neurotrophic activity and at least one adenosine A2A receptor antagonist for the manufacture of a medicament for the treatment, prevention or alleviation of Parkinson's disease in a subject |
01/09/2007 | US7160897 Therapeutic compounds |
01/09/2007 | US7160895 Inhibiting the proliferation of tumor cells, using 6-chloro-1,9-dimethyl-3-phenyl-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one; anticancer treatment |
01/09/2007 | US7160894 Antagonist of phosphorylation of myosin regulatory light chain, enzyme inhibitors; therapeutic treatment of glaucoma, bronchial asthma, chronic obstructive pulmonary disease, nervous system disorders; 4-(2,3-dihydro-1,5-diazaphenalen-1-yl)cyclohexylamine |
01/09/2007 | US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors |
01/09/2007 | US7160888 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-[1,8]naphthyridin-2-one; use in the treatment of central nervous system disorders, bipolar disorder in a human |
01/09/2007 | US7160886 For therapy and prophylaxis of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction |
01/09/2007 | US7160885 Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity |
01/09/2007 | US7160877 Aliphatic nitrogen-containing 5-membered ring compound |
01/09/2007 | US7160876 Fused bicycloheterocycle substituted quinuclidine derivatives |
01/09/2007 | US7160872 Methods to treat conditions mediated by chemokine receptors |
01/09/2007 | US7160485 Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives, related anisotropic films, and methods for making |
01/09/2007 | CA2338276C Fkbp inhibitors |
01/09/2007 | CA2196271C Quinolone- or naphthyridonecarboxylic acid derivative or salt thereof |
01/09/2007 | CA2186844C Use of serotonin antagonists (5ht3) for treating fibromyalgia |
01/09/2007 | CA2144293C Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases |
01/09/2007 | CA2142700C 3-oxo-pyrido(1,2-a)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders |
01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
01/08/2007 | CA2551616A1 A process for the purification of imiquimod |
01/04/2007 | WO2007002701A2 Anti-inflammatory aryl nitrile compounds |
01/04/2007 | WO2007002433A1 Pyrrolo [2, 3-b] pyridine derivatives as protein kinase inhibitors |
01/04/2007 | WO2007002325A1 Pyrrolo[2,3-b] pyridine derivatives as protein kinase inhibitors |
01/04/2007 | WO2007002114A1 1,2-dihydro-spiro(3h-indole-3-4’-piperidine) compounds as modulators of the mas receptor novel |
01/04/2007 | WO2007001975A1 Piperidine derivatives useful as histamine h3 antagonists |
01/04/2007 | WO2007001385A2 Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones |
01/04/2007 | WO2007000463A1 Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
01/04/2007 | WO2007000432A1 Oxazolidinone derivatives and use thereof as antibiotics |
01/04/2007 | WO2007000414A1 Method for production of substituted phenylmalonate esters novel phenylmalonate esters and use thereof |
01/04/2007 | WO2007000241A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
01/04/2007 | WO2007000043A2 Pyrazolo[3,4-b]pyridin-2-yl]-benzoic acid derivatives as hiv integrase inhibitors |
01/04/2007 | WO2006125194A3 Piperazine derivatives and their uses as therapeutic agents |
01/04/2007 | WO2006124462A3 Compounds and compositions as protein kinase inhibitors |
01/04/2007 | WO2006106423A3 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
01/04/2007 | WO2006078865B1 Direct racemization of indole derivatives |
01/04/2007 | WO2006073610A3 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
01/04/2007 | WO2006067614A3 Heteroaromatic derivatives useful as anticancer agents |
01/04/2007 | WO2006039325A3 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
01/04/2007 | WO2005069894A8 Conformationally constrained smac mimetics and the uses thereof |
01/04/2007 | US20070004919 Water-souluble, fluorescent perylenetetracarboxylic acid bisimides |
01/04/2007 | US20070004772 2-substituted 7-aryl-[1,2,4]triazolo[4,3-c]pyrimidin-3(2H)-one; mitogen-activated protein kinase inhibitor; physiological and psychotropic effects including regulation of appetite, immunosuppression, analgesia, inflammation, emesis, anti-nocioception, sedation, and intraocular pressure |
01/04/2007 | US20070004771 Preparation of 1,6,7-trisubstituted azabenzimidazoles as kinase inhibitors |
01/04/2007 | US20070004769 For a novel and efficient synthesis of compounds in which the pharmacophores of quinolone and oxazolidinone are linked to one another by way of a chemically stable linker |
01/04/2007 | US20070004768 Hydroxamates of isoquinolines, imidazopyridines and pyrrolopyridines, used to treat AIDS and AIDS-related complex |
01/04/2007 | US20070004765 New compounds |
01/04/2007 | US20070004755 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
01/04/2007 | US20070004754 Substituted pyrazoles |
01/04/2007 | US20070004747 Substituted pyrazoles |
01/04/2007 | US20070004740 phosphodiesterase 4 inhibitors which are naphthalene compounds such as 6,7-Dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene; asthma or inflammatory diseases |
01/04/2007 | US20070004739 Condensed polycyclic compounds |
01/04/2007 | US20070004738 Substituted pyrazoles |
01/04/2007 | US20070004736 Imidazole derivative, process for producing the same, and use |
01/04/2007 | US20070004714 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |